Media Registration Now Open for TCT 2018

Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in...
19-Apr-2018 3:45 PM EDT Add to Favorites

CRF to Hold Free Seminar on Diabetes and Heart Disease in New York City During American Heart Month

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” for the New York City community on Wednesday, February 7, 2018. The seminar, part of a series of Mini-Med Schools conducted by the...
31-Jan-2018 10:05 AM EST Add to Favorites

Latest Issue of Structural Heart: The Journal of the Heart Team is Now Available

The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team is now available online.
29-Jan-2018 10:05 AM EST Add to Favorites

CRF Invites the NYC Community to Attend Free Seminar on the Link Between Diabetes and Heart Disease During American Heart Month

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” on Wednesday, February 7, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF...
18-Jan-2018 2:05 PM EST Add to Favorites

Study Evaluates Safety of Three-Month Versus Standard Twelve-Month Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome Treated with a Drug-Eluting Stent

Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research...
1-Nov-2017 6:05 PM EDT Add to Favorites

Study Finds Six Months of Dual Antiplatelet Therapy May be Non-Inferior to Twelve Months in STEMI Patients Receiving Drug-Eluting Stents

The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ST-elevation myocardial infarction (STEMI) found six months of DAPT was non-inferior to 12 months of DAPT among patients treated with...
1-Nov-2017 6:05 PM EDT Add to Favorites

Synergy Stent with Shorter DAPT Is Superior to a Bare-Metal Stent in Elderly Patients

Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that...
1-Nov-2017 6:05 PM EDT Add to Favorites

Thirty-Day Results of ABSORB IV Demonstrate that Improvements in Bioresorbable Stent Technology and Technique are Still Needed

Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular scaffold (BVS) trial to date, found BVS to be noninferior to a cobalt-chromium everolimus-eluting stent (CoCr-EES) for target lesion failure (TLF).
31-Oct-2017 5:05 PM EDT Add to Favorites

see all news